Fig. 3

Mutational analysis during cancer evolution. Horizontal bar plots of evolution path analysis (left) and clonal selection analysis (right) with mutation features. “metastasis” versus “primary” (LC: Metastasis panel) and “progression disease (PD),” “partial response (PR),” and “stable disease” (SD) in lung cancer (LC: drug response panel). “good response” and “poor response” in CML sampled at diagnosis (CML: drug response panel). Only the top 10 terms with q value <  = 0.1 were shown. The bar indicates the mean Spearman correlation coefficient from each group. The standard error is shown as an error bar